Wegovy Pill: What to Know About the FDA-Approved Oral Option

Dr. Daniel McGee

Medically Reviewed

Dr. Daniel McGee, D.O.

Family Medicine Doctor

Written by Jake Dickson, NASM-CPT, USAW-L2

Published: June 30, 2026 8 Min Read
Wegovy pill bottle and white pills next to it placed on a kitchen countertop.

Key Takeaways

  • The Wegovy pill received FDA approval in December 2025 as an oral option for chronic weight management, taken once daily as a tablet rather than a weekly injection.
  • The pill and injection contain the same medication, but they are absorbed differently, so their dose numbers should not be compared directly.
  • Oral Wegovy uses a higher milligram dose because much less of the medication reaches the bloodstream after digestion.
  • Side effects and safety warnings are similar to those of injectable Wegovy, though daily dosing may affect how often some symptoms are felt.
  • Patients should ask their healthcare provider about current medications, side effects, pregnancy status, and whether an oral option is appropriate for their treatment needs.

Everyone faces different roadblocks on their weight loss journeys. The most common issues: Lack of motivation, time, social pressures, and cravings. What the science doesn’t show? Fear of needles.

GLP-1 medications can be “highly efficacious agents” when it comes to losing weight. But, until recently, they’ve only been available as a weekly injection—something you might not have the stomach for.

With the Wegovy pill, we finally have an alternative.

Is There a Wegovy Pill?

Yes, a Wegovy pill is available on the market as of January 2026. The Wegovy pill, a round, off-white, 7mm tablet, comes in packs of 30 ranging from 1.5mg to 25mg.

Some researchers have called the release of the Wegovy pill a “defining moment in the treatment of obesity” for providing an alternative delivery mechanism to patients in need.

What FDA Approval Means

The U.S. Food & Drug Administration (FDA) approved the Wegovy pill on Dec. 22, 2025—the first of its kind for chronic weight management.

A drug receives FDA approval only after extensive testing and research. The Wegovy pill, like any other medication, needed to meet the agency’s standards for safety and efficacy. For a full breakdown, refer to the Wegovy pill’s prescribing information.

Who the Wegovy Pill May Be Prescribed For

The Wegovy pill is intended for adults who are overweight or obese, just like the injectable version. And like injectable Wegovy, the pill is intended to be taken along with changes to lifestyle—more exercise, better judgment in the kitchen, and so on.

Infographic comparing Wegovy pill vs injection dosing: pill up to 25mg daily, injection up to 2.4mg weekly, showing why oral absorption requires a higher dose

How the Wegovy Pill Is Taken

Pills are the most convenient way to take regular medication. That convenience is the driving force behind the Wegovy pill—but you still need to pay attention to the drug’s prescribing information and safety warnings.

Daily Dosing

The Wegovy pill is taken once daily. For it to work properly, you must take it first thing in the morning on an empty stomach. Swallow the tablet completely whole. Do not split, crush, chew, or dissolve it. Take it with just a small sip of plain water (no more than 4 oz), and wait at least 30 minutes before having breakfast, coffee, or other oral medications.

Absorption Rates & Timing

Bioavailability describes how much of a medication actually makes it into the bloodstream. It’s affected by a number of variables like age, metabolism, digestive processes and, importantly, how you take the drug in the first place:

  • Injecting Wegovy results in ~90% bioavailability within 1-3 days.
  • Oral Wegovy reaches ~.75% bioavailability within one hour.

The peak plasma concentration of Wegovy isn’t relevant, since both oral and injectable Wegovy reach “saturation” in your system within 4 to 5 weeks.

It’s the stark difference in bioavailability that explains why the max-dose Wegovy pill has 10 times more of the medication than you’d take as an injection.

Follow the Label Closely

It is imperative to read the instructions carefully when taking any prescription drug. For the Wegovy pill, this is doubly true. It’s much more difficult to overdose, intentionally or otherwise, with a weekly injectable pen—how Ozempic and Wegovy have historically been administered—than taking tablets.

Following the label on the packaging reminds you of dosing safety, provides guidance on proper storage, and keeps side effects front-of-mind. Wegovy being available as a pill doesn’t turn it into aspirin; you need to be dutiful and attentive all the same.

Your Plan, Built Around You

Your Plan, Built Around You

Real results start with the right plan, not guesswork. A licensed provider can build a treatment path suited to your body and your goals.

Potential Benefits of an Oral GLP-1 Option

Oral GLP-1s are no different at a chemical level from their injectable cousins. Medications are developed in new formats to widen patient access. As such, most of the benefits of a GLP-1 pill are logistical:

  • Oral GLP-1s help people access the medication without having to interact with needles.
  • Tablets are more compact, easier to store or travel with, and don’t require refrigeration.
  • Injections can cause bruising or topical irritation, while pills don’t.

Common Side Effects and Safety Warnings

The Wegovy pill is exactly the same medication you’d get from an injection. All safety warnings and most side effects apply to both, but not necessarily at the same severity.

Remember—most semaglutide side effects are mild to moderate. However, changing the drug’s delivery mechanism can influence how you experience side effects. Trial data show oral semaglutide may have slightly higher rates of nausea and vomiting than injectable, while the latter may cause more diarrhea or constipation.

Why the disparity: Subcutaneous (under the skin) injections place the medication into the fatty tissue beneath the skin, where it is then absorbed directly into the bloodstream. Only a fraction of orally delivered medication actually reaches the bloodstream, hence the pill having a 10-times higher dose.

You also take the Wegovy pill daily, compared to a weekly injection. More frequent dosing can often mean more frequent side effects.


Not every patient wants a weekly injection, and for some people, the availability of an oral Wegovy option may remove an important barrier to treatment. I've seen patients who were reluctant to start a GLP-1 medication become much more comfortable when a pill became available. At the same time, oral medications aren't the best fit for everyone. Factors such as gastrointestinal side effects, other medications, and individual treatment preferences all play a role. That's why I encourage patients to have a conversation with their doctor about the pros and cons of each option so they can choose the approach that's most likely to be successful for them.

Dr. Daniel McGee, Board-certified Family Medicine Physician


Questions To Ask Your Doctor

If you’re thinking about trying the Wegovy pill, you need to get informed. That starts by talking to your doctor—whether you’re already on injectable Wegovy or are thinking about starting the medicine for the first time.

When you get to your appointment, keep these topics in mind:

Current medications: Wegovy slows the rate at which your body processes food, which can have downstream impacts on the absorption of other meds.

Side effects: If other medications, Wegovy injectables included, are giving you gastrointestinal side effects, the Wegovy pill might push it past the point of tolerability due to daily dosing.

Pregnancy status: Wegovy may be contraindicated for women who are pregnant or breastfeeding.

Bottom Line

The FDA's approval of the Wegovy pill gives patients a real alternative to a weekly injection, but it doesn't change the underlying medication or who it's meant for. The pill still requires daily dosing and a much higher milligram amount because of how poorly it absorbs compared to an injection.

That difference in absorption also explains why side effects can show up a little differently, even though the drug itself is the same. None of this makes the pill inherently better or worse than the injection, just a different delivery method with its own tradeoffs.

The right way to decide between them is still to talk to your doctor about your health history and current medications before making the switch.

Frequently Asked Questions

Yes, the Wegovy pill is FDA-approved as of late December 2025. It became available commercially in January 2026.


Yes, the Wegovy pill is the same as the injection with respect to the drug itself. Oral Wegovy is administered at a significantly higher dose because it is not absorbed in the same way as an injection.


You take the Wegovy pill once daily.


Yes. The Wegovy pill has a nearly identical side effect profile to the injection. Certain symptoms, such as gastrointestinal or digestive issues, may also impact how your body absorbs other medications.


Anyone with a history of thyroid cancer, high blood pressure, or who has had serious gastrointestinal issues should consult a doctor before going on the Wegovy pill.

Your Plan, Built Around You

Your Plan, Built Around You

Real results start with the right plan, not guesswork. A licensed provider can build a treatment path suited to your body and your goals.


  1. Fornes A, Huff J, Pritchard RI, Godfrey M. Once-Weekly Semaglutide for Weight Management: A Clinical Review. J Pharm Technol. 2022 Aug;38(4):239-246. doi: 10.1177/87551225221092681. Epub 2022 May 13. PMID: 35832567; PMCID: PMC9272494: https://pmc.ncbi.nlm.nih.gov/articles/PMC9272494/
  2. Deslippe AL, Soanes A, Bouchaud CC, Beckenstein H, Slim M, Plourde H, et al. Barriers and facilitators to diet, physical activity and lifestyle behavior intervention adherence: a qualitative systematic review of the literature. Int J Behav Nutr Phys Act. 2023 Feb 14;20(1):14. doi: 10.1186/s12966-023-01424-2. PMID: 36782207; PMCID: PMC9925368: https://link.springer.com/article/10.1186/s12966-023-01424-2
  3. Wharton S, Lingvay I, Bogdanski P, Duque do Vale R, Jacob S, Karlsson T, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. N Engl J Med. 2025 Sep 18;393(11):1077-1087. doi: 10.1056/NEJMoa2500969. PMID: 40934115: https://www.nejm.org/doi/10.1056/NEJMoa2500969
  4. Drugs.com. FDA approves Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults [Internet]. Drugs.com; 2025 Dec 22 [cited 2026 Jun 29]. Available from: https://www.drugs.com/newdrugs/fda-approves-novo-nordisk-s-wegovy-pill-first-only-oral-glp-1-weight-loss-adults-6701.html
  5. Alagga AA, Pellegrini MV, Gupta V. Drug absorption [Internet]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Updated 2024 Feb 27 [cited 2026 Jun 29]. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK557405/
  6. Novo Nordisk Inc. WEGOVY® (semaglutide) injection and WEGOVY® (semaglutide) tablets, prescribing information [Internet]. Plainsboro (NJ): Novo Nordisk Inc.; 2026 Jun [cited 2026 Jun 29]. Available from: https://www.novo-pi.com/wegovy.pdf
  7. Drugs.com. Semaglutide monograph for professionals [Internet]. Drugs.com; 2025 Dec 10 [cited 2026 Jun 29]. Available from: https://www.drugs.com/monograph/semaglutide.html
  8. Schweitzer K. What to Know About the New Semaglutide Pill for Obesity. JAMA. 2026 Feb 10;335(6):478-479. doi: 10.1001/jama.2026.0035. PMID: 41543841: https://jamanetwork.com/journals/jama/article-abstract/2844140
Jake Dickson, NASM-CPT, USAW-L2

By Jake Dickson, NASM-CPT, USAW-L2

Contributing Author

Jake holds a B.S. in Exercise Science from UNC Wilmington and began his career as a personal trainer and weightlifting coach. In recent years, he’s moved behind the page as a writer and editor, contributing hundreds of articles and being featured as a subject matter expert. Today, Jake’s goal remains the same: to empower people to change their lives by bringing heady scientific topics down to ground level.